Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GeneDx Holdings (WGS) Income from Continuing Operations (2020 - 2026)

GeneDx Holdings has reported Income from Continuing Operations over the past 7 years, most recently at 63316000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations fell 876.8% to 63316000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 77809000.0 through Mar 2026, down 101.95% year-over-year, with the annual reading at 21021000.0 for FY2025, 59.8% up from the prior year.
  • Income from Continuing Operations was 63316000.0 for Q1 2026 at GeneDx Holdings, down from 17714000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 10809000.0 in Q2 2025 and troughed at 308719000.0 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 29173000.0 (2024), against an average of 50662764.71.
  • Year-over-year, Income from Continuing Operations skyrocketed 137.05% in 2025 and then crashed 876.8% in 2026.
  • A 5-year view of Income from Continuing Operations shows it stood at 308719000.0 in 2022, then surged by 91.66% to 25758000.0 in 2023, then soared by 121.11% to 5438000.0 in 2024, then tumbled by 425.74% to 17714000.0 in 2025, then plummeted by 257.43% to 63316000.0 in 2026.
  • Per Business Quant, the three most recent readings for WGS's Income from Continuing Operations are 63316000.0 (Q1 2026), 17714000.0 (Q4 2025), and 7588000.0 (Q3 2025).